Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Carcinoma, Hepatocellular 4Recurrence 3Pancreatic Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Colorectal Neoplasms 3Burkitt Lymphoma 3Stomach Neoplasms 2Nasopharyngeal Carcinoma 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, Prolymphocytic, B-Cell 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid 2Leukemia, B-Cell 2Glioma 2Esophageal Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor 1Simpson-Golabi-Behmel syndrome 1Sarcoma, Synovial 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1

Interventions

Cisplatin 12Radiotherapy 6Gemcitabine 6Paclitaxel 5Fluorouracil 4Radiotherapy, Intensity-Modulated 3Docetaxel 3spartalizumab 2sintilimab 2nimotuzumab 2camrelizumab 2Surveys and Questionnaires 2Endostatins 2Carboplatin 2triethanolamine 1toripalimab 1regramostim 1fluzoparib 1fluoromisonidazole 1endostar protein 1Vitamin B 12 1Tomography, Optical Coherence 1Taxes 1Rubidium-82 1Ritonavir 1Re-Irradiation 1Procaine 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Nasopharyngeal Neoplasms × Immunotherapy, Adoptive × Clear all
NCT02980315 2016-12-02

A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application

The Second Hospital of Nanjing Medical University

Phase 1/2 Unknown
20 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡